C12Y 304/21077
Semenogelase , i.e. prostate specific antigen or psa or kallikrein 3
Official title: Semenogelase (3.4.21.77), i.e. prostate specific antigen or PSA or kallikrein 3
C12Y304/21077 (Semenogelase , i.e. prostate specific antigen or psa or kallikrein 3) appears on 22 US grants and 36 published applications in this corpus.
Search patents in C12Y- Granted patents
- 22
- Published applications
- 36
- Assignees
- 24
- Inventors
- 67
- Latest grant
- 14 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 6 |
| 2016 | 2 | 8 |
| 2017 | 5 | 2 |
| 2018 | 3 | 4 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 2 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same14 May 2024US 11,980,659 B2Inovio Pharmaceuticals, Inc.
- Compositions and methods comprising KLK3 or FOLH1 antigen20 Sep 2022US 11,446,369 B2Advaxis, Inc.
- Vectors for expression of prostate-associated antigens16 Nov 2021US 11,173,196 B2Pfizer Inc.
- Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same29 Jun 2021US 11,045,535 B2Inovio Pharmaceuticals, Inc.
- Analyzing apparatus28 May 2019US 10,302,638 B2Hirosaki University
- Prostate-specific membrane antigen targeted deep-tumor penetration of polymer nanodrugs and methods of use thereof5 Mar 2026US 2026/0061082 A1ProLynx LLC
- Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The Same27 Mar 2025US 2025/0101399 A1Inovio Pharmaceuticals, Inc.
- Standard substance for psa quantification, preparation method therefor, standard solution for psa quantification, and psa quantification method26 Jan 2023US 2023/0021481 A1Otsuka Pharmaceutical Co., Ltd.
- Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The Same20 Jan 2022US 2022/0016228 A1Inovio Pharmaceuticals, Inc.
- Compositions and methods comprising klk3 or folh1 antigen5 Mar 2020US 2020/0069785 A1Advaxis, Inc.
Most cited
By later US patents
- Structures for controlling light interaction with microfluidic devices43US 8,221,700 B2OPKO Diagnostics, LLC · 2012
- Structures for controlling light interaction with microfluidic devices28US 8,480,975 B2OPKO Diagnostics, LLC · 2013
- Structures for controlling light interaction with microfluidic devices18US 8,802,029 B2OPKO Diagnostics, LLC · 2014
- Compositions and methods comprising KLK3 or FOLH1 antigen16US 9,549,973 B2Advaxis, Inc. · 2017
- Compositions and methods comprising KLK3 of FOLH1 antigen13US 9,012,141 B2Advaxis, Inc. · 2015